N/A N=15 Randomized Single-blind Treatment

Community Participation Transition After Stroke

Stroke

Bottom Line

View on ClinicalTrials.gov: NCT02396589 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2024

Primary outcome: Primary: Rate and Severity of Falls (Calculated With an Algorithm) — 2; 2 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Education Group (Behavioral); Home Modifications Group (Behavioral)
Age: Adult, Older Adult · 45+ yrs
Sex: All
Sponsor: Washington University School of Medicine
Primary completion: Dec 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Rate and Severity of Falls (Calculated With an Algorithm)	2; 2	—
SECONDARY Intervention Dose (Minutes)	354.8; 365	—
SECONDARY Health Care Utilization, Number of Emergency Department Visits	.50; .56; 28.67; 26.11; 36.00; 19.44	—
SECONDARY Intervention Dose, Number of Treatment Sessions	4.4; 5	—
SECONDARY Health Care Utilization, Days of Hospitalization	0; .67	—

Summary

Stroke is one of the most serious, disabling health conditions in the United States. Patients who undergo rehabilitation treatment for stroke have a high rate of disability. Poor outcomes for many persons with stroke may be low because of incomplete treatment. The investigators will conduct a randomized controlled trial and a process evaluation to examine the feasibility, safety, and preliminary efficacy of an enhanced rehabilitation transition program, Community Participation Transition after Stroke (COMPASS), designed to bridge inpatient rehabilitation and the home to support the performance of everyday activities.

Eligibility Criteria

Inclusion Criteria

≥45 years old
acute ischemic stroke, verified by a neurologist
baseline National Institutes of Health Stroke Scale (NIHSS) ≥8
independent in activities of daily living prior to stroke (premorbid Rankin score of ≤2)
plan to discharge to home

Exclusion Criteria

severe terminal systemic disease that limits life expectancy to <6 months
previous disorder (e.g., dementia) that makes interpretation of the self-rated scales difficult or a Short Blessed Test (SBT) score of ≥9 (indicating significant cognitive impairment)
moderate to severe aphasia, as determined by the NIHSS Best Language rating of ≥2
residence in a congregate living facility
not eligible for a therapeutic pass

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02396589). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.